Literature DB >> 3964258

Characterization of an insulin-related factor secreted by a teratoma cell line.

Y Yamada, G Serrero.   

Abstract

The teratoma-derived insulin-independent cell line 1246-3A produces and secretes polypeptide mitogens in its culture serum-free medium. Mitogenic activities were separated by Sephadex G-50 chromatography into two fractions eluted, one in the void volume region, another one with an apparent Mr of 6 kDa. Only the 6 kDa mitogen presents properties similar to pancreatic insulin as estimated by radioimmunoassay, radio-receptor assay, and biochemical characterization. As a consequence, this factor is called insulin-related factor (IRF). Evidence presented in this paper indicate that ectopic IRF binds to insulin receptors on the producer cells, 1246-3A and acts in an autostimulatory manner.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3964258     DOI: 10.1016/0006-291x(86)90027-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Autocrine growth induced by the insulin-related factor in the insulin-independent teratoma cell line 1246-3A.

Authors:  Y Yamada; G Serrero
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

2.  Growth requirements, growth factor responsiveness, and growth factor secretion of three human embryonal carcinoma cell lines.

Authors:  W Verbeek; C Bokemeyer; H Falk; H J Schmoll
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

3.  In situ autoradiography and ligand-dependent tyrosine kinase activity reveal insulin receptors and insulin-like growth factor I receptors in prepancreatic chicken embryos.

Authors:  M Girbau; L Bassas; J Alemany; F de Pablo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

4.  Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26.

Authors:  M Koenuma; T Yamori; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1989-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.